Regeneration of Capto Core 700 resin through high throughput and laboratory scale studies and impact on production of a SARS-CoV-2 vaccine candidate.


Journal

Biotechnology journal
ISSN: 1860-7314
Titre abrégé: Biotechnol J
Pays: Germany
ID NLM: 101265833

Informations de publication

Date de publication:
Oct 2022
Historique:
revised: 03 06 2022
received: 29 04 2022
accepted: 24 06 2022
pubmed: 1 7 2022
medline: 12 10 2022
entrez: 30 6 2022
Statut: ppublish

Résumé

During the development of a SARS-CoV-2 vaccine candidate, at the height of the COVID-19 pandemic, raw materials shortages, including chromatography resins, necessitated the determination of a cleaning in place (CIP) strategy for a multimodal core-shell resin both rapidly and efficiently. Here, the deployment of high throughput (HT) techniques to screen CIP conditions for cleaning Capto Core 700 resin exposed to clarified cell culture harvest (CCCH) of a SARS-CoV-2 vaccine candidate produced in Vero adherent cell culture are described. The best performing conditions, comprised of 30% n-propanol and ≥0.75 N NaOH, were deployed in cycling experiments, completed with miniature chromatography columns, to demonstrate their effectiveness. The success of the CIP strategy was ultimately verified at the laboratory scale. Here, its impact was assessed across the entire purification process which also included an ultrafiltration/diafiltration step. It is shown that the implementation of the CIP strategy enabled the re-use of the Capto Core 700 resin for up to 10 cycles without any negative impact on the purified product. Hence, the strategic combination of HT and laboratory-scale experiments can lead rapidly to robust CIP procedures, even for a challenging to clean resin, and thus help to overcome supply shortages.

Identifiants

pubmed: 35771570
doi: 10.1002/biot.202200191
pmc: PMC9353343
doi:

Substances chimiques

COVID-19 Vaccines 0
Sodium Hydroxide 55X04QC32I
1-Propanol 96F264O9SV

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2200191

Informations de copyright

© 2022 The Authors. Biotechnology Journal published by Wiley-VCH GmbH.

Références

Farid, S. S. (2017). Process economic drivers in industrial monoclonal antibody manufacture. In U. Gottschalk (Ed.), Process scale purification of antibodies (pp. 445-465). John Wiley & Sons, Inc. https://doi.org/10.1002/9781119126942.ch21
Pollock, J., Bolton, G., Coffman, J., Ho, S. V., Bracewell, D. G., & Farid, S. S. (2013). Optimising the design and operation of semi-continuous affinity chromatography for clinical and commercial manufacture. Journal of Chromatography A, 1284, 17-27. https://doi.org/10.1016/j.chroma.2013.01.082
Grönberg, A., & Hjorth, R. A. (2018). Cleaning-in-place and sanitization. Biopharmaceutical processing (pp. 675-699). Elsevier. https://doi.org/10.1016/B978-0-08-100623-8.00033-5
Müller-Späth, T., Aumann, L., & Morbidelli, M. (2009). Role of cleaning-in-place in the purification of mAb supernatants using continuous cation exchange chromatography. Separation Science and Technology, 44(1), 1-26. https://doi.org/10.1080/01496390802581243
Wang, L., Dembecki, J., Jaffe, N. E., O'Mara, B. W., Cai, H., Sparks, C. N., Zhang, J., Laino, S. G., Russel, R. J., & Wang, M. (2013). A safe, effective, and facility compatible cleaning in place procedure for affinity resin in large-scale monoclonal antibody purification. Journal of Chromatography A, 1308, 86-95. https://doi.org/10.1016/j.chroma.2013.07.096
Rathore, A. S., Pathak, M., Ma, G., & Bracewell, D. G. (2015). Re-use of protein A resin: Fouling and economics. BioPharm International, 28(3), 28-33.
Rathore, A. S., & Sofer, G. (2005). Life span studies for chromatography and filtration media (pp. 169-203). CRC Press, Taylor and Francis Group. https://doi.org/10.1201/b12013
D'Amore, T., & Yang, Y. P. (2019). Advances and challenges in vaccine development and manufacture. BioProcess International, September 21. Available from: https://bioprocessintl.com/manufacturing/vaccines/advances-and-challenges-in-vaccine-development-and-manufacture/
Kis, Z., Shattock, R., Shah, N., & Kontoravdi, C. (2019). Emerging technologies for low-cost, rapid vaccine manufacture. Biotechnology Journal, 14(1), 1800376. https://doi.org/10.1002/biot.201800376
Plotkin, S., Robinson, J. M., Cunningham, G., Iqbal, R., & Larsen, S. (2017). The complexity and cost of vaccine manufacturing-an overview. Vaccine, 35(33), 4064-4071. https://doi.org/10.1016/j.vaccine.2017.06.003
Yang, Y. P. (2016). Advances in purification technologies accelerate vaccine development. American Pharmaceutical Review, 19(5), 52-59.
Lerer, E., Oren, Z., Kafri, Y., Adar, Y., Toister, E., Cherry, L., Lupu, E., Monash, A., Levy, R., Dor, E., Epstein, E., Levin, L., Girshengorn, M., Natan, N., Zichel, R., & Makovitzki, A. (2021). Highly efficient purification of recombinant VSV-∆ G-spike vaccine against SARS-CoV-2 by flow-through chromatography. BioTech, 10(4), 22. https://doi.org/10.3390/biotech10040022
Funkner, A., Dorner, S., Sewing, S., Kamm, J., Broghammer, N., Ketterer, T., & Mutzke, T. (2016). Method for producing and purifying RNA, comprising at least one step of tangential flow filtration World Intellectual Property Organization; PCT/EP2016/062152; WO/2016/193206, Germany 2016. https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2016193206
Weigel, T., Solomaier, T., Peuker, A., Pathapati, T., Wolff, M. W., & Reichl, U. (2014). A flow-through chromatography process for influenza A and B virus purification. Journal of Virological Methods, 207, 45-53. https://doi.org/10.1016/j.jviromet.2014.06.019
Mi, X., Fuks, P., Wang, S. C., Winters, M. A., & Carta, G. (2021). Protein AdsoProtein adsorption on core-shell particles: Comparison of Capto™ Core 400 and 700 Resins. Journal of Chromatography A, 1651, 462314, https://doi.org/10.1016/j.chroma.2021.462314
Konstantinidis, S., Goh, H. Y., Martin Bufájer, J. M., de Galbert, P., Parau, M., & Velayudhan, A. (2018). Flexible and accessible automated operation of miniature chromatography columns on a liquid handling station. Biotechnology Journal, 13(3), 1700390. https://doi.org/10.1002/biot.201700390
Grönberg, A., Eriksson, M., Ersoy, M., & Johansson, H. J. (2011). A tool for increasing the lifetime of chromatography resins. MAbs (Vol. 3, No. 2, pp. 192-202). Taylor & Francis. https://doi.org/10.4161/mabs.3.2.14874
Elich, T., Iskra, T., Daniels, W., & Morrison, C. J. (2016). High throughput determination of cleaning solutions to prevent the fouling of an anion exchange resin. Biotechnology and Bioengineering, 113(6), 1251-1259. https://doi.org/10.1002/bit.25881
McGown, E. L., Schroeder, K., & Hafeman, D. G. (1998). Verification of multichannel liquid dispenser performance in the 4-30 μL range by using optical pathlength measurements in microplates. Clinical Chemistry, 44(10), 2206-2208. https://doi.org/10.1093/clinchem/44.10.2206
Green, T. J., Zhang, X., Wertz, G. W., & Luo, M. (2006). Structure of the vesicular stomatitis virus nucleoprotein-RNA complex. Science, 313(5785), 357-360. https://doi.org/10.1126/science.1126953
Hochberg, Y., & Tamhane, A. C. (1987). Multiple comparison procedures. John Wiley & Sons, Inc. https://doi.org/10.1002/9780470316672
Kendall, M. G. (1970). Rank correlation methods. Griffin.
Occupational Safety and Health Administration. (1981). Occupational safety and health standards: Hazardous (classified) locations (Standard No. 1910.307).
Occupational Safety and Health Administration. (1974). Occupational safety and health standards: Hazardous materials (Standard No. 1910.106).
Sánchez-Trasviña, C., Fuks, P., Mushagasha, C., Kimerer, L., Mayolo-Deloisa, K., Rito-Palomares, M., & Carta, G. (2020). Structure and functional properties of Capto™ Core 700 core-shell particles. Journal of Chromatography A, 1621, 461079. https://doi.org/10.1016/j.chroma.2020.461079
Wiendahl, M., Schulze Wierling, P., Nielsen, J., Fomsgaard Christensen, D., Krarup, J., Staby, A., & Hubbuch, J. (2008). High throughput screening for the design and optimization of chromatographic processes-miniaturization, automation, and parallelization of breakthrough and elution studies. Chemical Engineering & Technology: Industrial Chemistry-Plant Equipment-Process Engineering-Biotechnology, 31(6), 893-903. https://doi.org/10.1002/ceat.200800167

Auteurs

Spyridon Konstantinidis (S)

Vaccine Process Research & Development, Merck & Co., Inc., Rahway, New Jersey, USA.

Seth R Reinhart (SR)

Vaccine Process Research & Development, Merck & Co., Inc., Rahway, New Jersey, USA.

Christine Castagna (C)

Vaccine Process Research & Development, Merck & Co., Inc., Rahway, New Jersey, USA.

Murphy R Poplyk (MR)

Vaccine Process Research & Development, Merck & Co., Inc., Rahway, New Jersey, USA.

Richard R Rustandi (RR)

Vaccine Analytical Research & Development, Merck & Co., Inc., Rahway, New Jersey, USA.

Kristen L Flor (KL)

Investigative Pathology, MRL, Merck & Co., Inc., Rahway, New Jersey, USA.

Jillian Acevedo-Skrip (J)

Vaccine Analytical Research & Development, Merck & Co., Inc., Rahway, New Jersey, USA.

Rachel Thompson (R)

Vaccine Analytical Research & Development, Merck & Co., Inc., Rahway, New Jersey, USA.

Christopher J Wang (CJ)

Vaccine Analytical Research & Development, Merck & Co., Inc., Rahway, New Jersey, USA.

Sheng-Ching Wang (SC)

Vaccine Process Research & Development, Merck & Co., Inc., Rahway, New Jersey, USA.

Michael A Winters (MA)

Vaccine Process Research & Development, Merck & Co., Inc., Rahway, New Jersey, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH